OI
ABMD

Oakbrook Investments’s Abiomed Inc ABMD Stock Holding History

Oakbrook Investments’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,200
Closed -$747K – 633
2019
Q3 		$747K Buy
4,200
+1,800
+75% +$389K 0.05% 298
2019
Q2 		$625K Sell
2,400
-1,450
-38% -$385K 0.04% 354
2019
Q1 		$1.1M Hold
3,850
– – 0.07% 237
2018
Q4 		$1.25M Sell
3,850
-270
-7% -$93.8K 0.08% 178
2018
Q3 		$1.85M Buy
4,120
+1,326
+47% +$523K 0.1% 162
2018
Q2 		$1.14M Sell
2,794
-821
-23% -$297K 0.07% 193
2018
Q1 		$1.05M Sell
3,615
-145
-4% -$36.7K 0.07% 220
2017
Q4 		$705K Sell
3,760
-60
-2% -$11.2K 0.04% 291
2017
Q3 		$644K Buy
3,820
+850
+29% +$129K 0.04% 293
2017
Q2 		$426K Sell
2,970
-655
-18% -$88K 0.03% 356
2017
Q1 		$454K Sell
3,625
-325
-8% -$37.7K 0.03% 357
2016
Q4 		$445K Buy
3,950
+475
+14% +$55K 0.03% 379
2016
Q3 		$447K Sell
3,475
-400
-10% -$47.9K 0.03% 377
2016
Q2 		$423K Buy
+3,875
New +$386K 0.02% 392

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Oakbrook Investments's ABMD Position: Q4 2019 in Review

Oakbrook Investments sold out of Abiomed Inc (ABMD) in Q4 2019, closing a stake of 4,200 shares — an estimated $747K sold.

Oakbrook Investments first reported a position in ABMD in Q2 2016 and held it in 14 quarters. The position peaked at $1.85M in Q3 2018. 465 funds tracked by Wall St. Rank hold ABMD as of Q4 2019.

  • Oakbrook Investments reported no remaining Abiomed Inc position as of Q4 2019 after selling out during the quarter.
  • Oakbrook Investments sold 4,200 Abiomed Inc shares in Q4 2019, an estimated $747K.
  • Oakbrook Investments first reported a position in Abiomed Inc in Q2 2016 and held it in 14 quarters.
  • Oakbrook Investments's Abiomed Inc position peaked at $1.85M in Q3 2018.
  • 465 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2019.

Based on Oakbrook Investments's 13F filing for Q4 2019, filed 6 Feb 2020.